Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis

ABSTRACT Objective: The aim of the study was to determine whether serum thymosin beta4 (Tβ4) can be a useful noninvasive biomarker to differentiate between nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver (NAFL). Methods: The study included 24 NAFL patients and 21 NASH patients....

Full description

Bibliographic Details
Main Authors: Yong Jiang, Tao Han, Zhi-Guang Zhang, Ying Zhang, Feng-Xiang Qi
Format: Article
Language:English
Published: Aran Ediciones
Series:Revista Espanola de Enfermedades Digestivas
Subjects:
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082018000100004&lng=en&tlng=en
_version_ 1811217281945960448
author Yong Jiang
Tao Han
Zhi-Guang Zhang
Ying Zhang
Feng-Xiang Qi
author_facet Yong Jiang
Tao Han
Zhi-Guang Zhang
Ying Zhang
Feng-Xiang Qi
author_sort Yong Jiang
collection DOAJ
description ABSTRACT Objective: The aim of the study was to determine whether serum thymosin beta4 (Tβ4) can be a useful noninvasive biomarker to differentiate between nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver (NAFL). Methods: The study included 24 NAFL patients and 21 NASH patients. The levels of Tβ4, 8-hydroxydeoxyguanosine acid (8-OhdG), liver function parameters, blood lipid, and glucose were detected in the venous blood of all patients. The NAFLD histological activity score (NAS) was examined in biopsy specimens from all patients. Statistical analysis was performed in order to find differences between the two abovementioned groups. In addition, receiver operator characteristic (ROC) analyses for alanine aminotransferase (ALT) and Tβ4 levels were performed in NAFL and NASH patients and the cut-off value was determined. Associations between the variables were tested using correlation coefficient calculations. Statistical significance was set at a p value of < 0.05. Results: Serum Tβ4 content was 5.12 ± 1.87 mg/l in the NAFL group and 2.98 ± 1.35 mg/l in the NASH group (p < 0.001). Serum Tβ4 content and NAS, histological features of hepatic steatosis, lobular inflammation and ballooning, ALT, glucose and 8-OhdG levels were negatively correlated (p < 0.05 for all) in the NASH group. The correlation coefficient values were -0.530, -0.562, -0.574, -0.438, -0.446, -0.426 and -0.563, respectively. On the basis of ROC analysis, the best predictive Tβ4 cut-off value for detecting NASH was 3.94 mg/l (85.7% sensitivity and 79.2% specificity, which were higher than those of ALT). Conclusion: Serum Tβ4 level can be used as a biomarker for the diagnosis of NASH and was negatively correlated with the oxidation state of the liver.
first_indexed 2024-04-12T06:52:51Z
format Article
id doaj.art-7e3b35e267944e9d9977ddc2e819bc9f
institution Directory Open Access Journal
issn 1130-0108
language English
last_indexed 2024-04-12T06:52:51Z
publisher Aran Ediciones
record_format Article
series Revista Espanola de Enfermedades Digestivas
spelling doaj.art-7e3b35e267944e9d9977ddc2e819bc9f2022-12-22T03:43:16ZengAran EdicionesRevista Espanola de Enfermedades Digestivas1130-01081101192410.17235/reed.2017.4690/2016S1130-01082018000100004Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitisYong JiangTao HanZhi-Guang ZhangYing ZhangFeng-Xiang QiABSTRACT Objective: The aim of the study was to determine whether serum thymosin beta4 (Tβ4) can be a useful noninvasive biomarker to differentiate between nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver (NAFL). Methods: The study included 24 NAFL patients and 21 NASH patients. The levels of Tβ4, 8-hydroxydeoxyguanosine acid (8-OhdG), liver function parameters, blood lipid, and glucose were detected in the venous blood of all patients. The NAFLD histological activity score (NAS) was examined in biopsy specimens from all patients. Statistical analysis was performed in order to find differences between the two abovementioned groups. In addition, receiver operator characteristic (ROC) analyses for alanine aminotransferase (ALT) and Tβ4 levels were performed in NAFL and NASH patients and the cut-off value was determined. Associations between the variables were tested using correlation coefficient calculations. Statistical significance was set at a p value of < 0.05. Results: Serum Tβ4 content was 5.12 ± 1.87 mg/l in the NAFL group and 2.98 ± 1.35 mg/l in the NASH group (p < 0.001). Serum Tβ4 content and NAS, histological features of hepatic steatosis, lobular inflammation and ballooning, ALT, glucose and 8-OhdG levels were negatively correlated (p < 0.05 for all) in the NASH group. The correlation coefficient values were -0.530, -0.562, -0.574, -0.438, -0.446, -0.426 and -0.563, respectively. On the basis of ROC analysis, the best predictive Tβ4 cut-off value for detecting NASH was 3.94 mg/l (85.7% sensitivity and 79.2% specificity, which were higher than those of ALT). Conclusion: Serum Tβ4 level can be used as a biomarker for the diagnosis of NASH and was negatively correlated with the oxidation state of the liver.http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082018000100004&lng=en&tlng=enThymosin beta48-hydroxy-deoxyguanosine acidNonalcoholic steatohepatitisNonalcoholic simple fatty liver
spellingShingle Yong Jiang
Tao Han
Zhi-Guang Zhang
Ying Zhang
Feng-Xiang Qi
Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis
Revista Espanola de Enfermedades Digestivas
Thymosin beta4
8-hydroxy-deoxyguanosine acid
Nonalcoholic steatohepatitis
Nonalcoholic simple fatty liver
title Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis
title_full Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis
title_fullStr Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis
title_full_unstemmed Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis
title_short Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis
title_sort serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis
topic Thymosin beta4
8-hydroxy-deoxyguanosine acid
Nonalcoholic steatohepatitis
Nonalcoholic simple fatty liver
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082018000100004&lng=en&tlng=en
work_keys_str_mv AT yongjiang serumthymosinbeta4asanoninvasivebiomarkerinpatientswithnonalcoholicsteatohepatitis
AT taohan serumthymosinbeta4asanoninvasivebiomarkerinpatientswithnonalcoholicsteatohepatitis
AT zhiguangzhang serumthymosinbeta4asanoninvasivebiomarkerinpatientswithnonalcoholicsteatohepatitis
AT yingzhang serumthymosinbeta4asanoninvasivebiomarkerinpatientswithnonalcoholicsteatohepatitis
AT fengxiangqi serumthymosinbeta4asanoninvasivebiomarkerinpatientswithnonalcoholicsteatohepatitis